News

EVI supports new EC-funded project that aims to strengthen international research and innovation cooperation between China and the EU

CEPI awards contract worth up to US$ 31 million to develop vaccine against Nipah virus

TRANSVAC2  project offers high-quality technical services to support the development of prophylactic and therapeutic vaccines for both human and animal use. These services are not restricted to any disease in particular.

Workshop will concentrate on latest advances in non-invasive imaging technologies

3rd Call for TRANSVAC Training Modules now advertised

The Multi-Stage Malaria Vaccine Consortium (MMVC) offers 3 PhD Fellowships in Malaria Research

EVI-supported project publishes first clinical results for vaccine candidate to prevent pregnancy-associated malaria.

European Commission highlights that EU-funded TRANSVAC2 project is developing infrastructure to support innovation and accelerate the development of new vaccines and thereby will enhance European competitiveness in this field and bring major societal benefits.

Deadline for submission: 7 March 2019, 16:00 (GMT)

Meeting report summarising the outcome of the EDUFLUVAC workshop on “Experimental animal models for universal influenza vaccines” has been published in Vaccine